Page last updated: 2024-09-05

sb 216763 and Muscular Atrophy, Spinal

sb 216763 has been researched along with Muscular Atrophy, Spinal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, C; Campillo, NE; Gil, C; Martinez, A; Morales-Garcia, JA; Palomo, V; Perez, C; Perez, DI; Perez-Castillo, AM; Reyes, JA; Roca, C; Rodríguez-Muela, N; Rubin, LL; Timchenko, L	1

Other Studies

1 other study(ies) available for sb 216763 and Muscular Atrophy, Spinal

Article	Year
Subtly Modulating Glycogen Synthase Kinase 3 β: Allosteric Inhibitor Development and Their Potential for the Treatment of Chronic Diseases. Journal of medicinal chemistry, 2017, 06-22, Volume: 60, Issue:12 Topics: Allosteric Site; beta Catenin; Chemistry Techniques, Synthetic; Drug Design; Drug Evaluation, Preclinical; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Humans; Induced Pluripotent Stem Cells; Molecular Docking Simulation; Molecular Dynamics Simulation; Muscular Atrophy, Spinal; Myoblasts, Skeletal; Myotonic Dystrophy; Quinolines; Structure-Activity Relationship	2017

Article

Year

Subtly Modulating Glycogen Synthase Kinase 3 β: Allosteric Inhibitor Development and Their Potential for the Treatment of Chronic Diseases.

Journal of medicinal chemistry, 2017, 06-22, Volume: 60, Issue:12

Topics: Allosteric Site; beta Catenin; Chemistry Techniques, Synthetic; Drug Design; Drug Evaluation, Preclinical; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Humans; Induced Pluripotent Stem Cells; Molecular Docking Simulation; Molecular Dynamics Simulation; Muscular Atrophy, Spinal; Myoblasts, Skeletal; Myotonic Dystrophy; Quinolines; Structure-Activity Relationship

2017